Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Angiotensin Ii, Des-asp
2. Des Asp Angiotensin Ii
3. Des Aspartyl Angiotensin Ii
4. Des-asp Angiotensin Ii
5. Des-aspartyl-angiotensin Ii
1. Angiotensin Iii, Human
2. 12687-51-3
3. Angiotensin Iii, Human, Mouse
4. 13602-53-4
5. Chebi:89666
6. (2s)-2-[[(2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic Acid
7. 5-ile-angiotensin Iii
8. Unii-xh7f04lxtf
9. Angiotensin Iii, 5-ile-
10. 1-desaspartyl-5-isoleucine Angiotensin Ii
11. Des-asp(1)-(ile(5))-angiotensin Ii
12. Angiotensin Ii, 1-desaspartyl-5-isoleucine-
13. Xh7f04lxtf
14. Des-asp-1-angiotensin Ii
15. Schembl9010604
16. Chembl1702539
17. Bdbm85557
18. Hy-p1540
19. Mfcd00167500
20. Akos024456669
21. Zinc169289390
22. Ncgc00167131-01
23. Cas_12687-51-3
24. Angiotensin Iii Trifluoroacetate Salt Hydrate
25. Cs-0044838
26. 1-de-l-aspartic Acid-5-l-isoleucine-angiotensin Ii
27. Angiotensin Iii (h-l-arg-l-val-l-tyr-l-ile-l-his-l-pro-l-phe-oh)
28. (2s)-2-{[(2s)-1-[(2s)-2-[(2s,3s)-2-[(2s)-2-[(2s)-2-[(2s)-2-amino-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic Acid
29. (s)-2-((s)-1-((6s,9s,12s,15s,18s)-18-((1h-imidazol-4-yl)methyl)-1,6-diamino-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxamido)-3-phenylpropanoic Acid
| Molecular Weight | 931.1 g/mol |
|---|---|
| Molecular Formula | C46H66N12O9 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 25 |
| Exact Mass | 930.50757173 g/mol |
| Monoisotopic Mass | 930.50757173 g/mol |
| Topological Polar Surface Area | 342 Ų |
| Heavy Atom Count | 67 |
| Formal Charge | 0 |
| Complexity | 1680 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Angiotensin III manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Angiotensin III, including repackagers and relabelers. The FDA regulates Angiotensin III manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Angiotensin III API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Angiotensin III supplier is an individual or a company that provides Angiotensin III active pharmaceutical ingredient (API) or Angiotensin III finished formulations upon request. The Angiotensin III suppliers may include Angiotensin III API manufacturers, exporters, distributors and traders.
Angiotensin III Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Angiotensin III GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Angiotensin III GMP manufacturer or Angiotensin III GMP API supplier for your needs.
A Angiotensin III CoA (Certificate of Analysis) is a formal document that attests to Angiotensin III's compliance with Angiotensin III specifications and serves as a tool for batch-level quality control.
Angiotensin III CoA mostly includes findings from lab analyses of a specific batch. For each Angiotensin III CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Angiotensin III may be tested according to a variety of international standards, such as European Pharmacopoeia (Angiotensin III EP), Angiotensin III JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Angiotensin III USP).
LOOKING FOR A SUPPLIER?
